Cargando…
Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD
Direct healthcare costs for patients with asthma are less than half (−52%) and for patients with COPD are 41% higher if compared to those of patients with bronchiectasis. The leading expense items in bronchiectasis are hospitalisations and antibiotics. https://bit.ly/3Iq8AUP
Autores principales: | Ronco, Raffaella, Franco, Giovanni, Monzio Compagnoni, Matteo, Aliberti, Stefano, Luppi, Fabrizio, Corrao, Giovani, Faverio, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388176/ https://www.ncbi.nlm.nih.gov/pubmed/37529638 http://dx.doi.org/10.1183/23120541.00158-2023 |
Ejemplares similares
-
Effectiveness and economic impact of Dupilumab in asthma: a population-based cohort study
por: Faverio, Paola, et al.
Publicado: (2023) -
Rehospitalization for pneumonia after first pneumonia admission: Incidence and predictors in a population-based cohort study
por: Faverio, Paola, et al.
Publicado: (2020) -
Assessing the physical healthcare gap among patients with severe mental illness: large real-world investigation from Italy
por: Corrao, Giovanni, et al.
Publicado: (2021) -
Change in healthcare during Covid-19 pandemic was assessed through observational designs
por: Corrao, Giovanni, et al.
Publicado: (2022) -
Monitoring of Essential Levels of mental healthcare during the Covid-19 epidemic outbreak. Evidence from an Italian Real-World study
por: Caggiu, G., et al.
Publicado: (2023)